Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers

被引:29
作者
Hedenstrom, H [1 ]
Alm, C
Kraft, M
Grahnen, A
机构
[1] Univ Hosp, Dept Clin Physiol, S-75085 Uppsala, Sweden
[2] Quintiles AB, Uppsala, Sweden
关键词
D O I
10.1046/j.1365-2036.1997.00264.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The therapeutic effect of drugs inhibiting acid production on acid-related discomforts is related to both the onset and duration of action of the drug. The effects on gastric pH by single oral doses of some acid-inhibiting drugs were investigated by measuring daytime (morning to lunch) intragastric pH in healthy volunteers. Methods: This randomized, single-dose, 4-way crossover study included 15 healthy fasting subjects. Effervescent ranitidine tablets 150 and 300 mg, fast-dissolving famotidine tablets 20 mg and capsules of omeprazole 20 mg were administered. Measurements of intragastric pH were performed every 4 s for 10 min prior to drug administration and during the following 4 h. Results: The effervescent ranitidine tablets (150 or 300 mg) produced similar changes in intragastric pH: following an immediate increase to about pH 5, intragastric pH decreased slightly over the next 10-20 min. Thereafter pH increased steadily, reaching pH 4 after 20-40 min and pH 6 after about 70 min. After famotidine, pH 4 was reached after 80 min, significantly slower than ranitidine. After omeprazole, pH 3 was never reached. Ranitidine 150 and 300 mg showed significantly larger integrated pH responses over the 4-h observation period, compared to famotidine (P = 0.0288 and 0.0074) or omeprazole (P < 0.001). Conclusions: After single-dose administration to healthy fasting volunteers), ranitidine effervescent tablets showed a significantly more rapid onset of action and a significantly larger integrated pH response compared to either famotidine 20 mg fast-dissolving tablets or omeprazole 20 mg capsules.
引用
收藏
页码:1137 / 1141
页数:5
相关论文
共 11 条
[1]  
ARNESTAD JS, 1996, SCAND J GASTROE S217, V31, pP4
[2]  
DEVIS G, 1993, ARCH INT PHARMACOD T, V322, P124
[3]  
ENGZELIUS JM, 1996, SCAND J GASTROE S217, V31, pP44
[4]  
HELLKE P, 1996, SCAND J GASTROE S217, V31, pP46
[5]   DYSPEPSIA IN ENGLAND AND SCOTLAND [J].
JONES, RH ;
LYDEARD, SE ;
HOBBS, FDR ;
KENKRE, JE ;
WILLIAMS, EI ;
JONES, SJ ;
REPPER, JA ;
CALDOW, JL ;
DUNWOODIE, WMB ;
BOTTOMLEY, JM .
GUT, 1990, 31 (04) :401-405
[6]  
JONES RH, 1994, BR J MED EC, V7, P99
[7]  
JONES RH, 1992, HELLENIC J GASTROENT, V5, P142
[8]  
LOSER C, 1994, ARZNEIMITTEL-FORSCH, V44-1, P626
[9]   EFFECT OF OMEPRAZOLE, A SUBSTITUTED BENZIMIDAZOLE, ON 24-H INTRAGASTRIC ACIDITY IN PATIENTS WITH PEPTIC-ULCER DISEASE [J].
NAESDAL, J ;
BODEMAR, G ;
WALAN, A .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1984, 19 (07) :916-922
[10]   THE PREVALENCE OF SYMPTOMS SUGGESTIVE OF ESOPHAGEAL DISORDERS [J].
RUTH, M ;
MANSSON, I ;
SANDBERG, N .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1991, 26 (01) :73-81